Table 1 Characteristics of respondents by healthcare system
From: Evidence-based smoking cessation treatment: a comparison by healthcare system
Characteristic | Total Sample N = 366 (%) | VHAa N = 93 (%) | AHCb N = 273 (%) |
|---|---|---|---|
Sociodemographic Characteristics | |||
 Gender, n (%) | |||
  Female | 206 (56.3) | 51 (54.8) | 155 (56.8) |
 Ethnicity/Race, n (%)c | |||
  Hispanic | 11 (3.0) | 2 (2.2) | 9 (3.3) |
  White | 297 (81.1) | 71 (76.3) | 226 (82.8) |
  Black | 22 (6.0) | 7 (7.5) | 15 (5.5) |
  Asian | 45 (12.3) | 15 (16.1) | 30 (11.0) |
  Other | 15 (4.1) | 4 (4.3) | 11 (4.0) |
Professional Characteristics | |||
 Medical Specialty, n (%) | |||
  General Internal Medicine | 215 (58.7) | 65 (69.9) | 150 (54.9) |
  Pulmonology | 39 (10.7) | 10 (10.8) | 29 (10.6) |
  Hematology/Oncology | 69 (18.9) | 18 (19.4) | 51 (18.7) |
  Gynecology | 43 (11.7) | 0 | 43 (15.8) |
 Medical Position, n (%) | |||
  Attending | 171 (46.7) | 45 (48.4) | 126 (46.2) |
  Physician-In-Training | 159 (43.4) | 31 (33.3) | 128 (46.9) |
  Nurse Practitioner | 33 (9.0) | 17 (18.3) | 16 (5.9) |
  Physician Assistant | 3 (0.8) | 0 | 3 (1.1) |
 Years Since Terminal Degree, n (%) | |||
   < 1 | 38 (10.4) | 5 (5.4) | 33 (12.1) |
  1–5 | 137 (37.4) | 29 (31.2) | 108 (39.6) |
  6–10 | 54 (14.8) | 13 (14.0) | 41 (15.0) |
  11–15 | 47 (12.8) | 11 (11.8) | 36 (13.2) |
  16–25 | 57 (15.6) | 25 (26.9) | 32 (11.7) |
   > 25 | 31 (8.5) | 10 (10.8) | 21 (7.7) |
  Missing | 2 (0.5) | 0 | 2 (0.7) |
 Practice Location, n (%) | |||
  Hospital-based clinic | 262 (71.6) | 58 (62.4) | 204 (74.7) |
  Community-based clinic | 104 (28.4) | 35 (37.6) | 69 (25.3) |
<  50% of Time Providing Direct Patient Care, n (%) | 87 (23.8) | 26 (28.0) | 61 (22.3) |
Perceived Percentage of Current Smokers in Healthcare Provider’s Practices, median (IQR) | 25 (15, 40) | 40 (30, 50) | 20 (15, 30) |
Perceived Percentage of Former Smokers in Healthcare Provider’s Practices, median (IQR) | 30 (20, 50) | 40 (25, 70) | 30 (20, 40) |
Perceived Effectiveness of Smoking Cessation at Decreasing Cancer Mortality, n (%) | |||
  Very Effective | 260 (71.0%) | 69 (74.2%) | 191 (70.0%) |
   < Very Effective | 104 (28.4%) | 23 (24.7%) | 81 (29.7%) |
  Missing | 2 (0.5%) | 1 (1.1%) | 1 (0.4%) |